Overview

TUDCA as a Therapy for Ulcerative Colitis (UC)

Status:
Recruiting
Trial end date:
2021-07-31
Target enrollment:
Participant gender:
Summary
This is a Phase I open label study examining the efficacy and safety of TUDCA (tauroursodeoxycholic acid) in ulcerative colitis treatment.
Phase:
Phase 1
Details
Lead Sponsor:
Washington University School of Medicine
Collaborator:
Crohn's and Colitis Foundation
Treatments:
Tauroursodeoxycholic acid